CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,406,615,000 | +904.4% | 65,943 | +381.8% | 0.01% | +400.0% |
| Q2 2022 | $339,164,000 | -83.9% | 13,687 | -83.7% | 0.00% | -66.7% |
| Q1 2022 | $2,102,245,000 | -39.9% | 83,855 | -12.8% | 0.00% | -40.0% |
| Q4 2021 | $3,500,093,000 | +96.6% | 96,130 | -7.6% | 0.01% | +66.7% |
| Q3 2021 | $1,779,956,000 | -9.4% | 104,091 | -5.4% | 0.00% | 0.0% |
| Q2 2021 | $1,964,554,000 | -68.6% | 110,088 | -9.9% | 0.00% | -66.7% |
| Q1 2021 | $6,259,017,000 | +40.8% | 122,151 | +70.1% | 0.01% | +12.5% |
| Q4 2020 | $4,445,732,000 | +598.6% | 71,798 | +518.3% | 0.01% | +700.0% |
| Q3 2020 | $636,392,000 | +158.8% | 11,613 | +171.8% | 0.00% | – |
| Q2 2020 | $245,868,000 | -58.4% | 4,273 | -71.0% | 0.00% | -100.0% |
| Q1 2020 | $591,048,000 | +212.0% | 14,710 | +207.1% | 0.00% | – |
| Q4 2019 | $189,444,000 | +366.4% | 4,790 | -20.0% | 0.00% | – |
| Q3 2019 | $40,619,000 | +72.7% | 5,991 | +136.9% | 0.00% | – |
| Q2 2019 | $23,520,000 | -63.9% | 2,529 | -46.1% | 0.00% | – |
| Q1 2019 | $65,227,000 | +59741.3% | 4,696 | +46860.0% | 0.00% | – |
| Q4 2018 | $109,000 | -98.8% | 10 | -98.6% | 0.00% | – |
| Q3 2018 | $9,328,000 | -4.0% | 738 | 0.0% | 0.00% | – |
| Q2 2018 | $9,719,000 | -86.7% | 738 | -86.2% | 0.00% | – |
| Q1 2018 | $72,923,000 | +136.7% | 5,362 | +3.6% | 0.00% | – |
| Q4 2017 | $30,809,000 | +92.3% | 5,178 | +139.8% | 0.00% | – |
| Q3 2017 | $16,020,000 | -26.7% | 2,159 | -7.5% | 0.00% | – |
| Q2 2017 | $21,846,000 | +4659.5% | 2,334 | +3604.8% | 0.00% | – |
| Q1 2017 | $459,000 | -94.5% | 63 | -94.5% | 0.00% | – |
| Q4 2016 | $8,406,000 | -10.6% | 1,136 | -27.0% | 0.00% | – |
| Q3 2016 | $9,398,000 | +148.9% | 1,556 | +85.0% | 0.00% | – |
| Q2 2016 | $3,776,000 | -91.2% | 841 | -84.2% | 0.00% | – |
| Q4 2015 | $43,044,000 | +8.9% | 5,314 | -18.6% | 0.00% | – |
| Q3 2015 | $39,519,000 | +106.4% | 6,532 | +180.7% | 0.00% | – |
| Q2 2015 | $19,151,000 | +289.6% | 2,327 | +257.5% | 0.00% | – |
| Q1 2015 | $4,915,000 | -36.3% | 651 | -62.0% | 0.00% | – |
| Q3 2014 | $7,718,000 | +17440.9% | 1,715 | +21337.5% | 0.00% | – |
| Q1 2014 | $44,000 | -97.6% | 8 | -97.5% | 0.00% | – |
| Q4 2013 | $1,841,000 | -98.7% | 318 | -96.9% | 0.00% | – |
| Q2 2013 | $144,483,000 | – | 10,218 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |